<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ivax corp. and webcast Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ivax+corp.+and+webcast.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to ivax corp. and webcast]]></description>
	<s:counts start="0" returned="3" found="3" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Teva to Webcast Ivax Acquisition Luncheon Presentation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_July_26/ai_n14818673]]></link>
		<description><![CDATA[JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) will host a special luncheon to review its proposed acquisition of Ivax Corporation (Amex:IVX) today at 1:00 p.m. Eastern Standard Time. Investors and other interested parties can access a live webcast of the event.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 26 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[TEVA to Acquire IVAX for $7.4 Billion; Combination Will Strengthen Global Leadership in Generics, Add New Product Lines and Growth Markets; The Companies will host a Webcast Conference Call at 08:30 EST]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_July_25/ai_n14816026]]></link>
		<description><![CDATA[JERUSALEM & MIAMI -- TEVA Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and IVAX Corporation (AMEX: IVX) jointly announced today that they have signed a definitive agreement providing for the acquisition of IVAX by TEVA. Under the terms of the agreement, shares of IVAX common stock will, at the election of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[TEVA to Acquire IVAX for $ 7.4 Billion; Combination Will Strengthen Global Leadership in Generics, Add New Product Lines and Growth Markets; The Companies will host a Webcast Conference Call at 08:30 EDT]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_July_25/ai_n14816027]]></link>
		<description><![CDATA[JERUSALEM & MIAMI -- TEVA Pharmaceutical Industries Ltd. (Nasdaq:TEVA) and IVAX Corporation (AMEX:IVX) jointly announced today that they have signed a definitive agreement providing for the acquisition of IVAX by TEVA. Under the terms of the agreement, shares of IVAX common stock will, at the election of the shareholder, be...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
